by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESC-HF 2026
Heart failure (HF) remains a major global health burden despite the availability of highly effective guideline-directed medical therapies (GDMT). However, the greatest challenge is no longer the discovery of therapies, but the establishment of healthcare systems capable of delivering rapid, protocol-driven, and sustained optimization of treatment. The findings were presented at Heart Failure 2026, organized by the European Society of Cardiology, held in Barcelona, from 9–12 May 2026.
Spain has emerged as a leading example of structured HF care through its nationwide network of accredited Heart Failure Units (HFUs), regarded as the country’s “secret weapon” for GDMT optimization. The Spanish Society of Cardiology developed a comprehensive accreditation framework categorizing HFUs into Community, Specialized, and Advanced HF Units based on complexity, infrastructure, and services provided. Accreditation requires compliance across seven core domains, including organizational structure, multidisciplinary staffing, care pathways, information systems, and performance indicators. Between 2017 and 2024, 101 HF units were accredited across Spain, including 54 Specialized HFUs, 33 Community HFUs, and 14 Advanced HFUs, representing approximately 80% of hospitals with HF units.
Spain’s HFU model emphasizes multidisciplinary care, nurse-led medication titration, rapid post-discharge review within 7–14 days, ambulatory worsening HF management, and strong integration with primary care through a hub-and-spoke system. Data from the A Coruña Specialized HF Unit involving 1,280 HF patients demonstrated marked improvements in GDMT prescription rates during follow-up, with beta-blocker use increasing to 94% and ACE inhibitor utilization to 92%. Observed mortality was significantly lower than predicted by MAGGIC risk scores, with 1-year mortality reduced from 19% predicted to 10.9% observed (P<0.001).
These findings highlight that Spain’s true innovation in HF management lies in organization, accreditation, protocolized care, and continuous quality evaluation, providing a scalable model for improving HF outcomes globally.